132 related articles for article (PubMed ID: 26647014)
21. Inhibition of rho kinase attenuates high flow induced pulmonary hypertension in rats.
Li FH; Xia W; Li AW; Zhao CF; Sun RP
Chin Med J (Engl); 2007 Jan; 120(1):22-9. PubMed ID: 17254483
[TBL] [Abstract][Full Text] [Related]
22. RhoA/rock signaling mediates peroxynitrite-induced functional impairment of Rat coronary vessels.
Sun Z; Wu X; Li W; Peng H; Shen X; Ma L; Liu H; Li H
BMC Cardiovasc Disord; 2016 Oct; 16(1):193. PubMed ID: 27724862
[TBL] [Abstract][Full Text] [Related]
23. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
[TBL] [Abstract][Full Text] [Related]
24. Long-term inhibition of Rho kinase with fasudil attenuates high flow induced pulmonary artery remodeling in rats.
Li F; Xia W; Li A; Zhao C; Sun R
Pharmacol Res; 2007 Jan; 55(1):64-71. PubMed ID: 17127075
[TBL] [Abstract][Full Text] [Related]
25. Targeting RhoA/ROCK pathway in pulmonary arterial hypertension.
Antoniu SA
Expert Opin Ther Targets; 2012 Apr; 16(4):355-63. PubMed ID: 22449260
[TBL] [Abstract][Full Text] [Related]
26. Vascular smooth muscle ROCK1 contributes to hypoxia-induced pulmonary hypertension development in mice.
Penumatsa KC; Singhal AA; Warburton RR; Bear MD; Bhedi CD; Nasirova S; Wilson JL; Qi G; Preston IR; Hill NS; Fanburg BL; Kim YB; Toksoz D
Biochem Biophys Res Commun; 2022 May; 604():137-143. PubMed ID: 35303680
[TBL] [Abstract][Full Text] [Related]
27. Rho kinase-mediated vasoconstriction in pulmonary hypertension.
McMurtry IF; Abe K; Ota H; Fagan KA; Oka M
Adv Exp Med Biol; 2010; 661():299-308. PubMed ID: 20204738
[TBL] [Abstract][Full Text] [Related]
28. Fasudil, a Rho‑kinase inhibitor, prevents intima‑media thickening in a partially ligated carotid artery mouse model: Effects of fasudil in flow‑induced vascular remodeling.
Zhang X; Zhang T; Gao F; Li Q; Shen C; Li Y; Li W; Zhang X
Mol Med Rep; 2015 Nov; 12(5):7317-25. PubMed ID: 26458725
[TBL] [Abstract][Full Text] [Related]
29. Betaine alleviates right ventricular failure via regulation of Rho A/ROCK signaling pathway in rats with pulmonary arterial hypertension.
Lv Y; Ma P; Wang J; Xu Q; Fan J; Yan L; Ma P; Zhou R
Eur J Pharmacol; 2021 Nov; 910():174311. PubMed ID: 34245749
[TBL] [Abstract][Full Text] [Related]
30. AMPK alpha 1-induced RhoA phosphorylation mediates vasoprotective effect of estradiol.
Gayard M; Guilluy C; Rousselle A; Viollet B; Henrion D; Pacaud P; Loirand G; Rolli-Derkinderen M
Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2634-42. PubMed ID: 21852563
[TBL] [Abstract][Full Text] [Related]
31. Activation of cold-sensing transient receptor potential melastatin subtype 8 antagonizes vasoconstriction and hypertension through attenuating RhoA/Rho kinase pathway.
Sun J; Yang T; Wang P; Ma S; Zhu Z; Pu Y; Li L; Zhao Y; Xiong S; Liu D; Zhu Z
Hypertension; 2014 Jun; 63(6):1354-63. PubMed ID: 24637663
[TBL] [Abstract][Full Text] [Related]
32. EP3 receptor deficiency attenuates pulmonary hypertension through suppression of Rho/TGF-β1 signaling.
Lu A; Zuo C; He Y; Chen G; Piao L; Zhang J; Xiao B; Shen Y; Tang J; Kong D; Alberti S; Chen D; Zuo S; Zhang Q; Yan S; Fei X; Yuan F; Zhou B; Duan S; Yu Y; Lazarus M; Su Y; Breyer RM; Funk CD; Yu Y
J Clin Invest; 2015 Mar; 125(3):1228-42. PubMed ID: 25664856
[TBL] [Abstract][Full Text] [Related]
33. Myeloid Notch1 deficiency activates the RhoA/ROCK pathway and aggravates hepatocellular damage in mouse ischemic livers.
Lu L; Yue S; Jiang L; Li C; Zhu Q; Ke M; Lu H; Wang X; Busuttil RW; Ying QL; Kupiec-Weglinski JW; Ke B
Hepatology; 2018 Mar; 67(3):1041-1055. PubMed ID: 29024000
[TBL] [Abstract][Full Text] [Related]
34. Rho Kinase Pathway Alterations in the Brain and Leukocytes in Huntington's Disease.
Narayanan KL; Chopra V; Rosas HD; Malarick K; Hersch S
Mol Neurobiol; 2016 May; 53(4):2132-40. PubMed ID: 25941073
[TBL] [Abstract][Full Text] [Related]
35. [Fasudil reverses monocrotaline-induced pulmonary hypertension in rats].
Jiang H; Guan RJ; Wang HY
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Mar; 41(3):239-44. PubMed ID: 23879951
[TBL] [Abstract][Full Text] [Related]
36. RhoA/Rho-kinase signaling: a therapeutic target in pulmonary hypertension.
Barman SA; Zhu S; White RE
Vasc Health Risk Manag; 2009; 5():663-71. PubMed ID: 19707285
[TBL] [Abstract][Full Text] [Related]
37. Metabotropic regulation of RhoA/Rho-associated kinase by L-type Ca2+ channels: new mechanism for depolarization-evoked mammalian arterial contraction.
Fernández-Tenorio M; Porras-González C; Castellano A; Del Valle-Rodríguez A; López-Barneo J; Ureña J
Circ Res; 2011 May; 108(11):1348-57. PubMed ID: 21493898
[TBL] [Abstract][Full Text] [Related]
38. [The effect of breviscapine on the pulmonary arterial pressure and the expression of Rho-kinase in pulmonary arterioles of hypoxic rats].
Yang L; Zheng BX; Cheng DY; Su QL; Fan LL; Yang YJ; Mu M; Chen WB
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov; 31(11):826-30. PubMed ID: 19080536
[TBL] [Abstract][Full Text] [Related]
39. Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells.
Xie Z; Su W; Guo Z; Pang H; Post SR; Gong MC
Cardiovasc Res; 2006 Feb; 69(2):491-501. PubMed ID: 16336954
[TBL] [Abstract][Full Text] [Related]
40. MIP-2 causes differential activation of RhoA in mouse aortic versus pulmonary artery endothelial cells.
Moldobaeva A; Baek A; Wagner EM
Microvasc Res; 2008 Jan; 75(1):53-8. PubMed ID: 17662312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
